Brief: Getinge's Subsidiary Maquet Cardiovascular Receives Adverse Jury Trial Verdict In Patent Infringement Dispute With Abiomed In U.S.
28/05/2026 17:38
BRIEF-Getinge's Subsidiary Maquet Cardiovascular Receives Adverse Jury Trial Verdict In Patent Infringement Dispute With Abiomed In U.S. May 28 (Reuters) - Getinge publ AB GETIb.ST:
GETINGE'S SUBSIDIARY MAQUET CARDIOVASCULAR RECEIVES ADVERSE JURY TRIAL VERDICT IN PATENT INFRINGEMENT DISPUTE WITH ABIOMED IN U.S.
GETINGE - VERDICT DOES NOT HAVE ANY NEGATIVE FINANCIAL OR OPERATIONAL IMPACT ON GETINGE
GETINGE: JURY FOUND THAT ABIOMED HAS NOT INFRINGED ANY MAQUET PATENTS RELATING TO INTRAVASCULAR HEART PUMP TECHNOLOGY
Source text: ID:nNDL8TczxD
Further company coverage: [GETIb.ST]
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Getinge publ AB
See all newsEurope Research Roundup: Akzo Nobel, Handelsbanken, RS Group
Medical gear maker Getinge beats Q3 profit estimates on pricing, product mix (updated)
Medical gear maker Getinge beats Q3 profit estimates on pricing, product mix
Sweden's Getinge Q3 organic sales rise 2.1%
Brief: Getinge Q3 Adjusted EBITA SEK 1,278 Million